| Date Filed | Type | Description |
| 01/05/2022 |
SC 13D/A
| New Enterprise Associates 12, Limited Partnership has filed a Schedule 13D for Liquidia Corporation |
| 12/29/2021 |
SC 13D/A
| New Enterprise Associates 12, Limited Partnership has filed a Schedule 13D for Ardelyx, Inc. |
| 03/10/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 03/10/2021 |
SC 13D/A
| New Enterprise Associates 12, Limited Partnership has filed a Schedule 13D for Trevena, Inc. |
| 07/07/2020 |
SC 13D/A
| New Enterprise Associates 12, Limited Partnership reports a 6.7% stake in Liquidia Technologies, Inc. |
| 06/18/2020 |
SC 13D/A
| New Enterprise Associates 12, Limited Partnership reports a 15.3% stake in Ardelyx, Inc. |
| 12/06/2019 |
SC 13D/A
| New Enterprise Associates 12, Limited Partnership has filed a Schedule 13D for Proteostasis Therapeutics, Inc. |
| 08/06/2018 |
SC 13D
| New Enterprise Associates 12, Limited Partnership reports a 16.7% stake in Liquidia Technologies, Inc. |
| 06/05/2018 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 03/06/2018 |
SC 13D/A
| New Enterprise Associates 12, Limited Partnership reports a 19.3% stake in Tintri, Inc. |
| 01/10/2018 |
SC 13G/A
| New Enterprise Associates 12, Limited Partnership has filed a Schedule 13D for Zosano Pharma Corporation |
| 12/21/2017 |
SC 13D/A
| New Enterprise Associates 12, Limited Partnership reports a 17% stake in Proteostasis Therapeutics, Inc. |
| 08/11/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 07/13/2017 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 02/13/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 09/20/2016 |
SC 13D/A
| PROTEOSTASIS THERAPEUTICS, INC. reports a 14.8% stake in Proteostasis Therapeutics, Inc. |
| 08/12/2016 |
SC 13D/A
| Groupon, Inc. reports a 3.8% stake in Groupon, Inc. |
| 07/28/2016 |
SC 13D/A
| ARDELYX, INC. reports a 43% stake in Ardelyx, Inc. |
| 06/16/2016 |
SC 13G/A
| OPOWER, INC. has filed a Schedule 13D for Opower, Inc. |
| 06/10/2016 |
SC 13D/A
| Groupon, Inc. reports a 5.9% stake in Groupon, Inc. |
| 04/15/2016 |
SC 13D
| Groupon, Inc. reports a 7.7% stake in Groupon, Inc. |
| 04/08/2016 |
SC 13D/A
| TriVascular Technologies, Inc. has filed a Schedule 13D for TriVascular Technologies, Inc. |
| 02/05/2016 |
SC 13G
| Zosano Pharma Corp reports a 18% stake in Zosano Pharma Corporation |
| 08/07/2012 |
SC 13D
| HYPERION THERAPEUTICS INC reports a 18.2% stake in Hyperion Therapeutics, Inc. |
| 02/13/2012 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 02/13/2012 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 02/05/2010 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 11/25/2009 |
SC 13D/A
| New Enterprise Associates 12, Limited Partnership has filed a Schedule 13D for Peplin, Inc. |
| 11/07/2008 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership |
| 12/22/2006 |
SC 13D
| New Enterprise Associates 12, Limited Partnership reports a 15.8% stake in HemoSense, Inc. |